TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 92,174 | 94,414 | 102,052 |
Financial expenses | 13 | 270 | 300 |
Earnings before taxes | -4,713 | 4,703 | 15,422 |
EBITDA | -4,535 | 5,287 | 16,229 |
Total assets | 49,761 | 43,787 | 50,259 |
Current assets | 49,127 | 42,963 | 49,035 |
Current liabilities | 25,351 | 13,763 | 22,230 |
Equity capital | 21,288 | 25,988 | 23,969 |
- share capital | 95 | 98 | 105 |
Employees (average) | 65 | 57 | 62 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 42.8% | 59.4% | 47.7% |
Turnover per employee | 1,418 | 1,656 | 1,646 |
Profit as a percentage of turnover | -5.1% | 5.0% | 15.1% |
Return on assets (ROA) | -9.4% | 11.4% | 31.3% |
Current ratio | 193.8% | 312.2% | 220.6% |
Return on equity (ROE) | -22.1% | 18.1% | 64.3% |
Change turnover | 597 | -587 | 12,793 |
Change turnover % | 1% | -1% | 14% |
Chg. No. of employees | 8 | -5 | 1 |
Chg. No. of employees % | 14% | -8% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.